References
- 1
Buckley P.
Receptor-binding profiles of antipsychotics: clinical strategies when switching between
agents.
J Clin Psychiatry.
2007;
68
(S 06)
5-9
- 2
Charfi F, Cohen D, Houeto J-L. et al .
Tardive dystonia induced by atypical neuroleptics: a case report with olanzapine.
J Child Adoles Psychopharmacol.
2004;
14
149-152
- 3
Dunayevich E, Strakowski S.
Olanzapine-induced tardive dystonia.
Am J Psychiatry.
1999;
156
1662
- 4
Garcia-Lado I, Garcia-Caballero A, Recimil MJ. et al .
Reappearance of tardive dystonia with olanzapine treated with clozapine.
Schizophr Res.
2005;
76
357-358
- 5
Gerlach J, Lublin H, Peacock L.
Extrapyramidal symptoms during long-term treatment with antipsychotics: special focus
on clozapine and D1 and D2 dopamine antagonists.
Neuropsychopharmacology.
1996;
14
S35-S39
- 6
Gourzis P, Polychronopoulos P, Papapetropoulos S. et al .
Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics:
a report of 2 cases.
Clin Neuropharmacol.
2005;
28
195-196
- 7
Gunal DI, Onultan O, Afsar N. et al .
Tardive dystonia associated with olanzapine therapy.
Neurological Sci.
2001;
22
331-332
- 8
Havaki-Kontaxaki B, Kontaxakis V, Christodoulou G.
Treatment of tardive pharyngolaryngeal dystonia with olanzapine.
Schizophr Res.
2004;
66
199-200
- 9
Horacek J, Bubenikova-Valesova V, Kopecek M. et al .
Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.
CNS Drugs.
2006;
20
389-409
- 10
Jaffe ME, Simpson GM.
Reduction of tardive dystonia with olanzapine.
Am J Psychiatry.
1999;
156
2016
- 11
Kapur S, Zipursky RB, Remington G. et al .
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
Am J Psychiatry.
1998;
155
921-928
- 12
Kiriakakis V, Bhatia KP, Quinn NP. et al .
The natural history of tardive dystonia A long-term follow-up study of 107 cases.
Brain.
1998;
121
2053-2066
- 13
Lucetti C, Bellini G, Nuti A. et al .
Treatment of patients with tardive dystonia with olanzapine.
Clin Neuropharmacol.
2002;
25
71-74
- 14
v Perrault G, Depoortere R, Morel E. et al .
Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic
D2/D3 dopamine receptor antagonist activity and limbic selectivity.
J Pharmacol Exp Ther.
1997;
280
73-82
- 15
Raja M, Azzoni A, Maisto G.
Three cases of improvement of tardive dyskinesia following olanzapine treatment.
Int J Neuropsychopharmacol.
1999;
2
333-334
- 16
Rauchverger B, Isakov V, Jabarin M.
Olanzapine-induced tardive dystonia successfully treated by tetrabenazine.
J Neuropsychiatry Clin Neurosci.
2007;
19
484-485
- 17
Seeman P.
Atypical antipsychotics: mechanism of action.
Can J Psychiatry.
2002;
47
27-38
- 18
Tarsy D, Baldessarini R, Tarazi F.
Effects of newer antipsychotics on extrapyramidal function.
CNS Drugs.
2002;
16
23-45
- 19
Tauscher J, Küfferle B, Asenbaum S. et al .
Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical
antipsychotics and haloperidol.
Psychopharmacology (Berl).
2002;
162
42-49
Correspondence
Dr. G.-C.-L. Hung
309 Songde Road
Xinyi District
Taipei City
Taiwan
Republic of China
Phone: +886/2/272 63141 ext: 1224
Fax: +886/2/272 62194
Email: galenhung@gmail.com
